Cargando…

Metastatic breast cancer: prolongation of survival in routine care is restricted to hormone-receptor- and Her2-positive tumors

18,000 women die due to metastatic breast cancer in Germany per year. Median survival is 20–28 months after diagnosis. The question we wanted to answer was whether survival has improved in routine care? For this purpose we conducted a retrospective analysis of all patients with metastatic breast can...

Descripción completa

Detalles Bibliográficos
Autores principales:	Weide, Rudolf, Feiten, Stefan, Friesenhahn, Vera, Heymanns, Jochen, Kleboth, Kristina, Thomalla, Jörg, van Roye, Christoph, Köppler, Hubert
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2014
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4177050/ https://www.ncbi.nlm.nih.gov/pubmed/25279326 http://dx.doi.org/10.1186/2193-1801-3-535

Ejemplares similares

Adherence assessment of patients with metastatic solid tumors who are treated in an oncology group practice
por: Feiten, Stefan, et al.
Publicado: (2016)

Treatment of Advanced Non Small Cell Lung Cancer in Routine Care: A Retrospective Analysis of 212 Consecutive Patients Treated in a Community Based Oncology Group Practice
por: Koeppler, Hubert, et al.
Publicado: (2009)

Curricular course for medical students at a hematology and oncology specialty practice, 2010-2022
por: Weide, Rudolf, et al.
Publicado: (2022)

Patients with indolent lymphomas are at high risk of infections: experience from a German outpatient clinic
por: Lutz, Christoph, et al.
Publicado: (2023)

Evaluation of psychosocial distress in patients treated in a community-based oncology group practice in Germany
por: Mergenthaler, U., et al.
Publicado: (2011)

Health status and infections in patients with symptomatic primary and secondary immunoglobulin G (IgG) deficiencies receiving intravenous IgG replacement
por: Weide, Rudolf, et al.
Publicado: (2020)

Is Prolonged Copper Restriction Needed in Pediatric Wilson’s Disease?
por: Hizarcıoğlu-Gülşen, Hayriye, et al.
Publicado: (2023)

HER2-targeted therapy prolongs survival in patients with HER2-positive breast cancer and intracranial metastatic disease: a systematic review and meta-analysis
por: Erickson, Anders W, et al.
Publicado: (2020)

Anti-HER2 antibody prolongs overall survival disproportionally more than progression-free survival in HER2-Positive metastatic breast cancer patients
por: Chen, I-Chun, et al.
Publicado: (2021)

HER2 expression should be routinely evaluated in DCIS to avoid under or overtreatment!
por: Garg, Nidhi, et al.
Publicado: (2023)

Mind After Uexküll: A Foray Into the Worlds of Ecological Psychologists and Enactivists
por: Feiten, Tim Elmo
Publicado: (2020)

Prolonged complete response after treatment withdrawal in HER2-overexpressed, hormone receptor-negative breast cancer with liver metastases: the prospect of disappearance of an incurable disease
por: Viel, Erika, et al.
Publicado: (2014)

The Effect of COVID-19 Restrictions on Routine Activities and Online Crime
por: Johnson, Shane D., et al.
Publicado: (2022)

Prolonged QTc in HIV-Infected Patients: A Need for Routine ECG Screening
por: Myerson, Merle, et al.
Publicado: (2019)

Antipsychotics in routine treatment are minor contributors to QT prolongation compared to genetics and age
por: Hommers, Leif, et al.
Publicado: (2021)

Prolonged Survival in Patients with Metastatic HER2-Positive Inflammatory Breast Cancer: A Case Report and Review of the Literature
por: Ge, Jennifer Y., et al.
Publicado: (2021)

The Prognostic Impact of Hormonal Receptor and HER-2 Expression Discordance in Metastatic Breast Cancer Patients
por: Yang, Ziyan, et al.
Publicado: (2020)

Bendamustine HCL for the treatment of relapsed indolent non-Hodgkin’s lymphoma
por: Weide, Rudolf
Publicado: (2008)

Calcium restriction prolongs metaphase in dividing Tradescantia stamen hair cells
Publicado: (1985)

Prolonged Sleep Restriction Affects Glucose Metabolism in Healthy Young Men
por: van Leeuwen, Wessel M. A., et al.
Publicado: (2010)

Neoadjuvant pertuzumab in non-metastatic HER2-positive breast tumors: Multicentric study in Peru (NeoHer)
por: Falcon, Silvia, et al.
Publicado: (2022)

Combination of tucatinib and neural stem cells secreting anti-HER2 antibody prolongs survival of mice with metastatic brain cancer
por: Cordero, Alex, et al.
Publicado: (2021)

Sneaky side effects and ineffectiveness of an immunotherapy with ipilimumab in a case of metastatic melanoma
por: Krecké, Nathalie, et al.
Publicado: (2016)

Current Landscape of Targeted Therapies for Hormone-Receptor Positive, HER2 Negative Metastatic Breast Cancer
por: Ballinger, Tarah J., et al.
Publicado: (2018)

Hormonal treatment combined with targeted therapies in endocrine-responsive and HER2-positive metastatic breast cancer
por: Montagna, Emilia, et al.
Publicado: (2019)

Characterization of Hormone Receptor and HER2 Status in Breast Cancer Using Mass Spectrometry Imaging
por: Gonçalves, Juliana Pereira Lopes, et al.
Publicado: (2023)

Prolonged in vivo expression and anti-tumor response of DNA-based anti-HER2 antibodies
por: Hollevoet, Kevin, et al.
Publicado: (2018)

Role of hormonal risk factors in HER2-positive breast carcinomas
por: Balsari, A, et al.
Publicado: (2003)

Triple Targeting of Breast Tumors Driven by Hormonal Receptors and HER2
por: Shagisultanova, Elena, et al.
Publicado: (2022)

Nuclear T-STAR Protein Expression Correlates with HER2 Status, Hormone Receptor Negativity and Prolonged Recurrence Free Survival in Primary Breast Cancer and Decreased Cancer Cell Growth In Vitro
por: Sernbo, Sandra, et al.
Publicado: (2013)

Predictors of fulvestrant long-term benefit in hormone receptor-positive/HER2 negative advanced breast cancer
por: Torrisi, Rosalba, et al.
Publicado: (2022)

The GOAT-Ghrelin System Is Not Essential for Hypoglycemia Prevention during Prolonged Calorie Restriction
por: Yi, Chun-Xia, et al.
Publicado: (2012)

Insights into the beneficial effect of caloric/ dietary restriction for a healthy and prolonged life
por: Pallavi, Rani, et al.
Publicado: (2012)

Exposure–response analysis of pertuzumab in HER2-positive metastatic breast cancer: absence of effect on QTc prolongation and other ECG parameters
por: Garg, Amit, et al.
Publicado: (2013)

Dual HER2 Suppression with Lapatinib plus Trastuzumab for Metastatic Inflammatory Breast Cancer: A Case Report of Prolonged Stable Disease
por: Ogawa, Lauren, et al.
Publicado: (2018)

Daytime QT by Routine 12-Lead ECG Is Prolonged in Patients with Severe Obstructive Sleep Apnea
por: Walker, McCall, et al.
Publicado: (2020)

Lapatinib plus Letrozole as First-Line Therapy for HER-2(+) Hormone Receptor–Positive Metastatic Breast Cancer
por: Schwartzberg, Lee S., et al.
Publicado: (2010)

THE EFFECT OF PROLONGED APPLICATION OF LARGE DOSES OF FOLLICULAR HORMONE ON THE UTERUS OF RABBITS
por: Zondek, Bernhard
Publicado: (1936)

Effect of prolonged stress on the adrenal hormones of individuals with irritable bowel syndrome
por: Sugaya, Nagisa, et al.
Publicado: (2015)

Syndrome of inappropriate antidiuretic hormone secretion associated with prolonged keterolac use
por: Lim, Sian Yik, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_8k7aatdlmih48bd8ljn3n8beiv